Search

everythinglearnresearchcommunity

for

Search:↓

The environment around the time of conception can change the VTRNA2-1 gene in a way that lasts for years and may affect disease risk.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Ayurvedic remedies may boost immunity and balance in cancer treatment but need more research.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

The skin and thymus develop similarly to protect and support immunity.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Korean Red Ginseng has beneficial components that help with stress, immunity, fatigue, memory, blood flow, and disease protection.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

The skin is vital for protection, temperature control, fluid balance, immunity, and sensing, with damage affecting daily life and mental health.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Cell death shapes skin stem cell environments, affecting inflammation, repair, and cancer.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Some stem cells in the body rarely divide, which could help create better treatments for diseases and aging.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

TLR2 is important for hair growth and can be targeted to treat hair loss.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

ATP-dependent chromatin remodeling is crucial for skin development and stem cell function.